| Year |
Citation |
Score |
| 2024 |
Wang R, Cen M, Huang Y, Qian G, Dean NE, Ellenberg SS, Fleming TR, Lu W, Longini IM. Methods for the estimation of direct and indirect vaccination effects by combining data from individual- and cluster-randomized trials. Statistics in Medicine. PMID 38348581 DOI: 10.1002/sim.10030 |
0.368 |
|
| 2023 |
Prasad PV, Steele MK, Reed C, Meyers LA, Du Z, Pasco R, Alfaro-Murillo JA, Lewis B, Venkatramanan S, Schlitt J, Chen J, Orr M, Wilson ML, Eubank S, Wang L, ... ... Longini I, et al. Multimodeling approach to evaluating the efficacy of layering pharmaceutical and nonpharmaceutical interventions for influenza pandemics. Proceedings of the National Academy of Sciences of the United States of America. 120: e2300590120. PMID 37399393 DOI: 10.1073/pnas.2300590120 |
0.39 |
|
| 2023 |
Song S, Madewell ZJ, Liu M, Longini IM, Yang Y. Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies. Frontiers in Public Health. 11: 1195908. PMID 37361171 DOI: 10.3389/fpubh.2023.1195908 |
0.322 |
|
| 2023 |
Gozzi N, Chinazzi M, Dean NE, Longini IM, Halloran ME, Perra N, Vespignani A. Estimating the impact of COVID-19 vaccine inequities: a modeling study. Nature Communications. 14: 3272. PMID 37277329 DOI: 10.1038/s41467-023-39098-w |
0.376 |
|
| 2023 |
Hladish TJ, Pillai AN, Pearson CAB, Toh KB, Tamayo A, Stoltzfus A, Longini IM. Evaluating targeted COVID-19 vaccination strategies with agent-based modeling. Medrxiv : the Preprint Server For Health Sciences. PMID 36945423 DOI: 10.1101/2023.03.09.23285319 |
0.399 |
|
| 2022 |
Gozzi N, Chinazzi M, Dean NE, Longini IM, Halloran ME, Perra N, Vespignani A. Estimating the impact of COVID-19 vaccine allocation inequities: a modeling study. Medrxiv : the Preprint Server For Health Sciences. PMID 36415459 DOI: 10.1101/2022.11.18.22282514 |
0.382 |
|
| 2022 |
Cross RW, Longini IM, Becker S, Bok K, Boucher D, Carroll MW, Díaz JV, Dowling WE, Draghia-Akli R, Duworko JT, Dye JM, Egan MA, Fast P, Finan A, Finch C, et al. An introduction to the Marburg virus vaccine consortium, MARVAC. Plos Pathogens. 18: e1010805. PMID 36227853 DOI: 10.1371/journal.ppat.1010805 |
0.39 |
|
| 2022 |
Longini IM, Yang Y, Fleming TR, Muñoz-Fontela C, Wang R, Ellenberg SS, Qian G, Halloran ME, Nason M, Gruttola V, Mulangu S, Huang Y, Donnelly CA, Henao Restrepo AM. A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats. Clinical Trials (London, England). 17407745221110880. PMID 35866633 DOI: 10.1177/17407745221110880 |
0.399 |
|
| 2022 |
Madewell ZJ, Yang Y, Longini IM, Halloran ME, Dean NE. Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis. Jama Network Open. 5: e229317. PMID 35482308 DOI: 10.1001/jamanetworkopen.2022.9317 |
0.322 |
|
| 2022 |
Dean NE, Longini IM. The ring vaccination trial design for the estimation of vaccine efficacy and effectiveness during infectious disease outbreaks. Clinical Trials (London, England). 17407745211073594. PMID 35057647 DOI: 10.1177/17407745211073594 |
0.374 |
|
| 2022 |
Madewell ZJ, Yang Y, Longini IM, Halloran ME, Dean NE. Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis. Medrxiv : the Preprint Server For Health Sciences. PMID 35043125 DOI: 10.1101/2022.01.09.22268984 |
0.317 |
|
| 2021 |
Krause PR, Fleming TR, Longini IM, Peto R, Briand S, Heymann DL, Beral V, Snape MD, Rees H, Ropero AM, Balicer RD, Cramer JP, Muñoz-Fontela C, Gruber M, Gaspar R, et al. SARS-CoV-2 Variants and Vaccines. The New England Journal of Medicine. PMID 34161052 DOI: 10.1056/NEJMsr2105280 |
0.375 |
|
| 2021 |
Fleming TR, Nason M, Krause PR, Longini IM, Henao-Restrepo AM. COVID-19 vaccine trials: The potential for "hybrid" analyses. Clinical Trials (London, England). 17407745211018613. PMID 34041932 DOI: 10.1177/17407745211018613 |
0.364 |
|
| 2021 |
Fleming TR, Krause PR, Nason M, Longini IM, Henao-Restrepo AM. COVID-19 vaccine trials: The use of active controls and non-inferiority studies. Clinical Trials (London, England). 1740774520988244. PMID 33535811 DOI: 10.1177/1740774520988244 |
0.375 |
|
| 2020 |
Krause PR, Fleming TR, Longini IM, Peto R, Beral V, Bhargava B, Cravioto A, Cramer J, Ellenberg SS, Figueroa JP, Halloran E, Henao-Restrepo AM, Ryan MJ, Levine MM, et al. Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them. The New England Journal of Medicine. PMID 33264543 DOI: 10.1056/NEJMp2033538 |
0.314 |
|
| 2020 |
Dean NE, Pastore Y Piontti A, Madewell ZJ, Cummings DAT, Hitchings MDT, Joshi K, Kahn R, Vespignani A, Halloran ME, Longini IM. Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials. Vaccine. PMID 33012602 DOI: 10.1016/j.vaccine.2020.09.031 |
0.303 |
|
| 2020 |
Krause P, Fleming TR, Longini I, Henao-Restrepo AM, Peto R. COVID-19 vaccine trials should seek worthwhile efficacy. Lancet (London, England). PMID 32861315 DOI: 10.1016/S0140-6736(20)31821-3 |
0.439 |
|
| 2020 |
Aleta A, Martín-Corral D, Pastore Y Piontti A, Ajelli M, Litvinova M, Chinazzi M, Dean NE, Halloran ME, Longini IM, Merler S, Pentland A, Vespignani A, Moro E, Moreno Y. Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19. Nature Human Behaviour. PMID 32759985 DOI: 10.1038/S41562-020-0931-9 |
0.308 |
|
| 2020 |
Lee EC, Chao DL, Lemaitre JC, Matrajt L, Pasetto D, Perez-Saez J, Finger F, Rinaldo A, Sugimoto JD, Halloran ME, Longini IM, Ternier R, Vissieres K, Azman AS, Lessler J, et al. Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study. The Lancet. Global Health. 8: e1081-e1089. PMID 32710864 DOI: 10.1016/S2214-109X(20)30310-7 |
0.465 |
|
| 2020 |
Jing QL, Liu MJ, Zhang ZB, Fang LQ, Yuan J, Zhang AR, Dean NE, Luo L, Ma MM, Longini I, Kenah E, Lu Y, Ma Y, Jalali N, Yang ZC, et al. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study. The Lancet. Infectious Diseases. PMID 32562601 DOI: 10.1016/S1473-3099(20)30471-0 |
0.326 |
|
| 2020 |
Dean NE, Halloran ME, Longini IM. Temporal Confounding in the Test Negative Design. American Journal of Epidemiology. PMID 32415834 DOI: 10.1093/Aje/Kwaa084 |
0.44 |
|
| 2020 |
Zhang J, Litvinova M, Wang W, Wang Y, Deng X, Chen X, Li M, Zheng W, Yi L, Chen X, Wu Q, Liang Y, Wang X, Yang J, Sun K, ... Longini IM, et al. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. The Lancet. Infectious Diseases. PMID 32247326 DOI: 10.1016/S1473-3099(20)30230-9 |
0.332 |
|
| 2020 |
Dean NE, Gsell PS, Brookmeyer R, Crawford FW, Donnelly CA, Ellenberg SS, Fleming TR, Halloran ME, Horby P, Jaki T, Krause PR, Longini IM, Mulangu S, Muyembe-Tamfum JJ, Nason MC, et al. Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks. The New England Journal of Medicine. 382: 1366-1369. PMID 32242365 DOI: 10.1056/Nejmsb1905390 |
0.341 |
|
| 2020 |
Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, Pastore Y Piontti A, Mu K, Rossi L, Sun K, Viboud C, Xiong X, Yu H, Halloran ME, Longini IM, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science (New York, N.Y.). PMID 32144116 DOI: 10.1126/Science.Aba9757 |
0.375 |
|
| 2020 |
Hladish TJ, Pearson CAB, Toh KB, Rojas DP, Manrique-Saide P, Vazquez-Prokopec GM, Halloran ME, Longini IM. Designing effective control of dengue with combined interventions. Proceedings of the National Academy of Sciences of the United States of America. PMID 31974303 DOI: 10.1073/Pnas.1903496117 |
0.493 |
|
| 2020 |
Halloran ME, Longini IM, Gilbert PB. Designing a Study of Correlates of Risk for Ebola Vaccination. American Journal of Epidemiology. PMID 31971229 DOI: 10.1093/Aje/Kwaa001 |
0.477 |
|
| 2019 |
Dean NE, Gsell PS, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, Jasseh M, Nason M, Riveros X, Watson CH, Henao-Restrepo AM, Longini IM. Design of vaccine efficacy trials during public health emergencies. Science Translational Medicine. 11. PMID 31270270 DOI: 10.1126/Scitranslmed.Aat0360 |
0.436 |
|
| 2019 |
Bellan SE, Eggo RM, Gsell PS, Kucharski AJ, Dean NE, Donohue R, Zook M, Edmunds WJ, Odhiambo F, Longini IM, Brisson M, Mahon BE, Henao-Restrepo AM. An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool. Vaccine. PMID 31242963 DOI: 10.1016/J.Vaccine.2019.06.019 |
0.442 |
|
| 2019 |
Robert A, Edmunds WJ, Watson CH, Henao-Restrepo AM, Gsell PS, Williamson E, Longini IM, Sakoba K, Kucharski AJ, Touré A, Nadlaou SD, Diallo B, Barry MS, Fofana TO, Camara L, et al. Determinants of transmission risk during the late stage of the West African Ebola epidemic. American Journal of Epidemiology. PMID 30941398 DOI: 10.1093/Aje/Kwz090 |
0.316 |
|
| 2019 |
Tsang TK, Ghebremariam SL, Gresh L, Gordon A, Halloran ME, Katzelnick LC, Rojas DP, Kuan G, Balmaseda A, Sugimoto J, Harris E, Longini IM, Yang Y. Effects of infection history on dengue virus infection and pathogenicity. Nature Communications. 10: 1246. PMID 30886145 DOI: 10.1038/S41467-019-09193-Y |
0.385 |
|
| 2018 |
Pavía-Ruz N, Barrera-Fuentes GA, Villanueva-Jorge S, Che-Mendoza A, Campuzano-Rincón JC, Manrique-Saide P, Rojas DP, Vazquez-Prokopec GM, Halloran ME, Longini IM, Gómez-Dantés H. Dengue seroprevalence in a cohort of schoolchildren and their siblings in Yucatan, Mexico (2015-2016). Plos Neglected Tropical Diseases. 12: e0006748. PMID 30462654 DOI: 10.1371/Journal.Pntd.0006748 |
0.312 |
|
| 2018 |
Rojas DP, Barrera-Fuentes GA, Pavia-Ruz N, Salgado-Rodriguez M, Che-Mendoza A, Manrique-Saide P, Vazquez-Prokopec GM, Halloran ME, Longini IM, Gomez-Dantes H. Epidemiology of dengue and other arboviruses in a cohort of school children and their families in Yucatan, Mexico: Baseline and first year follow-up. Plos Neglected Tropical Diseases. 12: e0006847. PMID 30462635 DOI: 10.1371/Journal.Pntd.0006847 |
0.35 |
|
| 2018 |
Sun K, Zhang Q, Pastore-Piontti A, Chinazzi M, Mistry D, Dean NE, Rojas DP, Merler S, Poletti P, Rossi L, Halloran ME, Longini IM, Vespignani A. Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015-2016 ZIKV epidemic. Bmc Medicine. 16: 195. PMID 30336778 DOI: 10.1186/S12916-018-1185-5 |
0.343 |
|
| 2018 |
Zarnitsyna VI, Bulusheva I, Handel A, Longini IM, Halloran ME, Antia R. Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks. Plos One. 13: e0199674. PMID 29944709 DOI: 10.1371/Journal.Pone.0199674 |
0.514 |
|
| 2018 |
Hladish TJ, Pearson CAB, Patricia Rojas D, Gomez-Dantes H, Halloran ME, Vazquez-Prokopec GM, Longini IM. Forecasting the effectiveness of indoor residual spraying for reducing dengue burden. Plos Neglected Tropical Diseases. 12: e0006570. PMID 29939983 DOI: 10.1371/Journal.Pntd.0006570 |
0.322 |
|
| 2018 |
Tsang TK, Chen TM, Longini IM, Halloran ME, Wu Y, Yang Y. Transmissibility of Norovirus in Urban versus Rural Households in a Large Community Outbreak in China. Epidemiology (Cambridge, Mass.). PMID 29847497 DOI: 10.1097/Ede.0000000000000855 |
0.308 |
|
| 2018 |
Dean NE, Halloran ME, Longini IM. Design Of Vaccine Trials During Outbreaks With And Without A Delayed Vaccination Comparator. The Annals of Applied Statistics. 12: 330-347. PMID 29606991 DOI: 10.1214/17-Aoas1095 |
0.493 |
|
| 2018 |
Longini IM, Røttingen J, Kieny MP, Edmunds WJ, Henao-Restrepo AM. Questionable efficacy of the rVSV-ZEBOV Ebola vaccine - Authors' reply. The Lancet. 391: 1021-1022. PMID 29565012 DOI: 10.1016/S0140-6736(18)30559-2 |
0.456 |
|
| 2018 |
Bisanzio D, Dzul-Manzanilla F, Gomez-Dantés H, Pavia-Ruz N, Hladish TJ, Lenhart A, Palacio-Vargas J, Roldan JFG, Correa-Morales F, Sánchez-Tejeda G, Morales PK, Manrique-Saide P, Longini IM, Halloran ME, Vazquez-Prokopec GM. Spatio-temporal coherence of dengue, chikungunya and Zika outbreaks in Merida, Mexico Plos Neglected Tropical Diseases. 12. PMID 29543910 DOI: 10.1371/Journal.Pntd.0006298 |
0.345 |
|
| 2018 |
Pavía-Ruz N, Rojas DP, Villanueva S, Granja P, Balam-May A, Longini IM, Halloran ME, Manrique-Saide P, Gómez-Dantés H. Seroprevalence of Dengue Antibodies in Three Urban Settings in Yucatan, Mexico. American Journal of Tropical Medicine and Hygiene. 98: 1202-1208. PMID 29460714 DOI: 10.4269/Ajtmh.17-0382 |
0.307 |
|
| 2017 |
Gsell PS, Camacho A, Kucharski AJ, Watson CH, Bagayoko A, Danmadji S, Dean NE, Diallo A, Diallo A, Djidonou H, Doumbia M, Enwere G, Higgs ES, Mauget T, Mory D, ... ... Longini IM, et al. Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report. The Lancet. Infectious Diseases. PMID 29033032 DOI: 10.1016/S1473-3099(17)30541-8 |
0.487 |
|
| 2017 |
Yang Y, Meng Y, Halloran ME, Longini IM. Dependency of Vaccine Efficacy on Pre-Exposure and Age: A Closer Look at a Tetravalent Dengue Vaccine. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29020332 DOI: 10.1093/Cid/Cix766 |
0.46 |
|
| 2017 |
Wichmann O, Vannice K, Asturias EJ, de Albuquerque Luna EJ, Longini I, Lopez AL, Smith PG, Tissera H, Yoon IK, Hombach J. Live-attenuated tetravalent dengue vaccines: The needs and challenges of post-licensure evaluation of vaccine safety and effectiveness. Vaccine. PMID 28893477 DOI: 10.1016/J.Vaccine.2017.08.066 |
0.498 |
|
| 2017 |
Wilder-Smith A, Longini I, Zuber PL, Bärnighausen T, Edmunds WJ, Dean N, Spicher VM, Benissa MR, Gessner BD. The public health value of vaccines beyond efficacy: methods, measures and outcomes. Bmc Medicine. 15: 138. PMID 28743299 DOI: 10.1186/S12916-017-0911-8 |
0.454 |
|
| 2017 |
Zhang Q, Sun K, Chinazzi M, Pastore Y Piontti A, Dean NE, Rojas DP, Merler S, Mistry D, Poletti P, Rossi L, Bray M, Halloran ME, Longini IM, Vespignani A. Spread of Zika virus in the Americas. Proceedings of the National Academy of Sciences of the United States of America. PMID 28442561 DOI: 10.1073/Pnas.1620161114 |
0.397 |
|
| 2017 |
Kirpich A, Weppelmann TA, Yang Y, Morris JG, Longini IM. Controlling cholera in the Ouest Department of Haiti using oral vaccines. Plos Neglected Tropical Diseases. 11: e0005482. PMID 28410382 DOI: 10.1371/Journal.Pntd.0005482 |
0.49 |
|
| 2016 |
Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet (London, England). PMID 28017403 DOI: 10.1016/S0140-6736(16)32621-6 |
0.481 |
|
| 2016 |
Flasche S, Jit M, Rodríguez-Barraquer I, Coudeville L, Recker M, Koelle K, Milne G, Hladish TJ, Perkins TA, Cummings DA, Dorigatti I, Laydon DJ, España G, Kelso J, Longini I, et al. The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study. Plos Medicine. 13: e1002181. PMID 27898668 DOI: 10.1371/Journal.Pmed.1002181 |
0.478 |
|
| 2016 |
Merler S, Ajelli M, Fumanelli L, Parlamento S, Pastore Y Piontti A, Dean NE, Putoto G, Carraro D, Longini IM, Halloran ME, Vespignani A. Containing Ebola at the Source with Ring Vaccination. Plos Neglected Tropical Diseases. 10: e0005093. PMID 27806049 DOI: 10.1371/Journal.Pntd.0005093 |
0.497 |
|
| 2016 |
Koepke AA, Longini IM, Halloran ME, Wakefield J, Minin VN. PREDICTIVE MODELING OF CHOLERA OUTBREAKS IN BANGLADESH. The Annals of Applied Statistics. 10: 575-595. PMID 27746850 DOI: 10.1214/16-Aoas908 |
0.378 |
|
| 2016 |
Ajelli M, Merler S, Fumanelli L, Pastore Y Piontti A, Dean NE, Longini IM, Halloran ME, Vespignani A. Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis. Bmc Medicine. 14: 130. PMID 27600737 DOI: 10.1186/S12916-016-0678-3 |
0.445 |
|
| 2016 |
Rojas DP, Dean NE, Yang Y, Kenah E, Quintero J, Tomasi S, Ramirez EL, Kelly Y, Castro C, Carrasquilla G, Halloran ME, Longini IM. The epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016. Euro Surveillance : Bulletin EuropéEn Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 21. PMID 27452806 DOI: 10.2807/1560-7917.Es.2016.21.28.30283 |
0.334 |
|
| 2016 |
Feldstein LR, Matrajt L, Halloran ME, Keitel WA, Longini IM. Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies Vaccine. 34: 3796-3802. PMID 27268778 DOI: 10.1016/J.Vaccine.2016.05.067 |
0.496 |
|
| 2016 |
Hladish TJ, Pearson CA, Chao DL, Rojas DP, Recchia GL, Gómez-Dantés H, Halloran ME, Pulliam JR, Longini IM. Projected Impact of Dengue Vaccination in Yucatán, Mexico. Plos Neglected Tropical Diseases. 10: e0004661. PMID 27227883 DOI: 10.1371/Journal.Pntd.0004661 |
0.514 |
|
| 2016 |
Reiner RC, Achee N, Barrera R, Burkot TR, Chadee DD, Devine GJ, Endy T, Gubler D, Hombach J, Kleinschmidt I, Lenhart A, Lindsay SW, Longini I, Mondy M, Morrison AC, et al. Quantifying the Epidemiological Impact of Vector Control on Dengue. Plos Neglected Tropical Diseases. 10: e0004588. PMID 27227829 DOI: 10.1371/Journal.Pntd.0004588 |
0.376 |
|
| 2016 |
Kieny MP, Longini IM, Henao-Restrepo AM, Watson CH, Egger M, Edmunds WJ. Changes in the primary outcome in Ebola vaccine trial--Authors' reply. Lancet (London, England). 387: 1509-10. PMID 27115974 DOI: 10.1016/S0140-6736(16)00686-3 |
0.398 |
|
| 2016 |
Fang LQ, Yang Y, Jiang JF, Yao HW, Kargbo D, Li XL, Jiang BG, Kargbo B, Tong YG, Wang YW, Liu K, Kamara A, Dafae F, Kanu A, Jiang RR, ... ... Longini IM, et al. Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone. Proceedings of the National Academy of Sciences of the United States of America. PMID 27035948 DOI: 10.1073/Pnas.1518587113 |
0.394 |
|
| 2016 |
Dean NE, Halloran ME, Yang Y, Longini IM. The transmissibility and pathogenicity of Ebola virus: a systematic review and meta-analysis of household secondary attack rate and asymptomatic infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26932131 DOI: 10.1093/Cid/Ciw114 |
0.318 |
|
| 2016 |
Kenah E, Britton T, Halloran ME, Longini IM. Molecular Infectious Disease Epidemiology: Survival Analysis and Algorithms Linking Phylogenies to Transmission Trees Plos Computational Biology. 12. DOI: 10.1371/Journal.Pcbi.1004869 |
0.35 |
|
| 2015 |
Longini IM, Egger M, Dean NE, Edmunds WJ, Henao-Restrepo AM. Ebola vaccination - Authors' reply The Lancet. 386: 2480. PMID 26738716 DOI: 10.1016/S0140-6736(15)00951-4 |
0.457 |
|
| 2015 |
Matrajt L, Britton T, Halloran ME, Longini IM. One versus two doses: What is the best use of vaccine in an influenza pandemic? Epidemics. 13: 17-27. PMID 26616038 DOI: 10.1016/J.Epidem.2015.06.001 |
0.469 |
|
| 2015 |
Kirpich A, Weppelmann TA, Yang Y, Ali A, Morris JG, Longini IM. Cholera Transmission in Ouest Department of Haiti: Dynamic Modeling and the Future of the Epidemic. Plos Neglected Tropical Diseases. 9: e0004153. PMID 26488620 DOI: 10.1371/Journal.Pntd.0004153 |
0.35 |
|
| 2015 |
Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Hossmann S, Kondé MK, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet (London, England). 386: 857-66. PMID 26248676 DOI: 10.1016/S0140-6736(15)61117-5 |
0.462 |
|
| 2015 |
Camacho A, Carroll MW, Dean NE, Doumbia M, Edmunds WJ, Egger M, Enwere G, Hall Y, Henao-Restrepo AM, Hossmann S, Keita S, Kondé MK, Longini IM, Mandal S, Norheim G, et al. The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola Bmj. PMID 26215666 DOI: 10.1136/Bmj.H3740 |
0.479 |
|
| 2015 |
Schwartz LM, Halloran ME, Durbin AP, Longini IM. The dengue vaccine pipeline: Implications for the future of dengue control. Vaccine. 33: 3293-3298. PMID 25989449 DOI: 10.1016/J.Vaccine.2015.05.010 |
0.478 |
|
| 2015 |
Chao DL, Park JK, Marks F, Ochiai RL, Longini IM, Halloran ME. The contribution of neighbours to an individual's risk of typhoid outcome. Epidemiology and Infection. 1-8. PMID 25936682 DOI: 10.1017/S0950268815000692 |
0.401 |
|
| 2015 |
Lipsitch M, Eyal N, Halloran ME, Hernán MA, Longini IM, Perencevich EN, Grais RF. Vaccine testing. Ebola and beyond. Science (New York, N.Y.). 348: 46-8. PMID 25838371 DOI: 10.1126/Science.Aaa3178 |
0.518 |
|
| 2015 |
Yang Y, Zhang Y, Fang L, Halloran ME, Ma M, Liang S, Kenah E, Britton T, Chen E, Hu J, Tang F, Cao W, Feng Z, Longini IM. Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014. Euro Surveillance : Bulletin EuropéEn Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 20: 21056. PMID 25788253 DOI: 10.2807/1560-7917.Es2015.20.10.21056 |
0.364 |
|
| 2015 |
Merler S, Ajelli M, Fumanelli L, Gomes MF, Piontti AP, Rossi L, Chao DL, Longini IM, Halloran ME, Vespignani A. Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational modelling analysis. The Lancet. Infectious Diseases. 15: 204-11. PMID 25575618 DOI: 10.1016/S1473-3099(14)71074-6 |
0.362 |
|
| 2015 |
Matrajt L, Britton T, Halloran ME, Longini IM. One versus two doses: What is the best use of vaccine in an influenza pandemic? Epidemics. 13: 17-27. DOI: 10.1016/j.epidem.2015.06.001 |
0.367 |
|
| 2014 |
Gomes MF, Pastore Y Piontti A, Rossi L, Chao D, Longini I, Halloran ME, Vespignani A. Assessing the international spreading risk associated with the 2014 west african ebola outbreak. Plos Currents. 6. PMID 25642360 DOI: 10.1371/Currents.Outbreaks.Cd818F63D40E24Aef769Dda7Df9E0Da5 |
0.395 |
|
| 2014 |
Tran CH, Sugimoto JD, Pulliam JR, Ryan KA, Myers PD, Castleman JB, Doty R, Johnson J, Stringfellow J, Kovacevich N, Brew J, Cheung LL, Caron B, Lipori G, Harle CA, ... ... Longini IM, et al. School-located influenza vaccination reduces community risk for influenza and influenza-like illness emergency care visits. Plos One. 9: e114479. PMID 25489850 DOI: 10.1371/Journal.Pone.0114479 |
0.46 |
|
| 2014 |
Dimitrov DT, Troeger C, Halloran ME, Longini IM, Chao DL. Comparative effectiveness of different strategies of oral cholera vaccination in bangladesh: a modeling study. Plos Neglected Tropical Diseases. 8: e3343. PMID 25473851 DOI: 10.1371/Journal.Pntd.0003343 |
0.477 |
|
| 2014 |
Poletto C, Gomes MF, Pastore y Piontti A, Rossi L, Bioglio L, Chao DL, Longini IM, Halloran ME, Colizza V, Vespignani A. Assessing the impact of travel restrictions on international spread of the 2014 West African Ebola epidemic. Euro Surveillance : Bulletin Europã©En Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 19. PMID 25358040 DOI: 10.2807/1560-7917.Es2014.19.42.20936 |
0.314 |
|
| 2014 |
Halloran ME, Longini IM. Emerging, evolving, and established infectious diseases and interventions. Science (New York, N.Y.). 345: 1292-4. PMID 25214617 DOI: 10.1126/Science.1254166 |
0.453 |
|
| 2014 |
Chao DL, Longini IM, Morris JG. Modeling cholera outbreaks. Current Topics in Microbiology and Immunology. 379: 195-209. PMID 23412687 DOI: 10.1007/82_2013_307 |
0.329 |
|
| 2013 |
Chao DL, Longini IM, Halloran ME. The effects of vector movement and distribution in a mathematical model of dengue transmission. Plos One. 8: e76044. PMID 24204590 DOI: 10.1371/Journal.Pone.0076044 |
0.397 |
|
| 2013 |
Matrajt L, Halloran ME, Longini IM. Optimal vaccine allocation for the early mitigation of pandemic influenza. Plos Computational Biology. 9: e1002964. PMID 23555207 DOI: 10.1371/Journal.Pcbi.1002964 |
0.498 |
|
| 2012 |
Chao DL, Halstead SB, Halloran ME, Longini IM. Controlling dengue with vaccines in Thailand. Plos Neglected Tropical Diseases. 6: e1876. PMID 23145197 DOI: 10.1371/Journal.Pntd.0001876 |
0.491 |
|
| 2012 |
Potter GE, Handcock MS, Longini IM, Halloran ME. ESTIMATING WITHIN-SCHOOL CONTACT NETWORKS TO UNDERSTAND INFLUENZA TRANSMISSION. The Annals of Applied Statistics. 6: 1-26. PMID 22639701 DOI: 10.1214/11-Aoas505 |
0.321 |
|
| 2012 |
Yang Y, Longini IM, Halloran ME, Obenchain V. A hybrid EM and Monte Carlo EM algorithm and its application to analysis of transmission of infectious diseases. Biometrics. 68: 1238-49. PMID 22506893 DOI: 10.1111/J.1541-0420.2012.01757.X |
0.361 |
|
| 2012 |
Beatty M, Boni MF, Brown S, Buathong R, Burke D, Coudeville L, Cummings DA, Edelman R, Farrar J, Focks DA, Gomes MG, Guignard A, Halstead S, Hombach J, ... ... Longini I, et al. Assessing the potential of a candidate dengue vaccine with mathematical modeling. Plos Neglected Tropical Diseases. 6: e1450. PMID 22479655 DOI: 10.1371/journal.pntd.0001450 |
0.356 |
|
| 2012 |
Longini IM. A theoretic framework to consider the effect of immunizing schoolchildren against influenza: Implications for research Pediatrics. 129. PMID 22383483 DOI: 10.1542/Peds.2011-0737D |
0.499 |
|
| 2012 |
Matrajt L, Longini IM. Critical immune and vaccination thresholds for determining multiple influenza epidemic waves Epidemics. 4: 22-32. PMID 22325011 DOI: 10.1016/J.Epidem.2011.11.003 |
0.424 |
|
| 2012 |
Chao DL, Bloom JD, Kochin BF, Antia R, Longini IM. The global spread of drug-resistant influenza. Journal of the Royal Society, Interface / the Royal Society. 9: 648-56. PMID 21865253 DOI: 10.1098/Rsif.2011.0427 |
0.329 |
|
| 2012 |
Chao D, Halstead S, Halloran M, Longini I. A mathematical model for the control of dengue using vaccines International Journal of Infectious Diseases. 16: e301. DOI: 10.1016/J.Ijid.2012.05.985 |
0.46 |
|
| 2011 |
Potter GE, Handcock MS, Longini IM, Halloran ME. ESTIMATING WITHIN-HOUSEHOLD CONTACT NETWORKS FROM EGOCENTRIC DATA. The Annals of Applied Statistics. 5: 1816-1838. PMID 22427793 DOI: 10.1214/11-Aoas474 |
0.339 |
|
| 2011 |
Kenah E, Chao DL, Matrajt L, Halloran ME, Longini IM. The global transmission and control of influenza. Plos One. 6: e19515. PMID 21573121 DOI: 10.1371/Journal.Pone.0019515 |
0.49 |
|
| 2011 |
Chao DL, Halloran ME, Longini IM. Vaccination strategies for epidemic cholera in Haiti with implications for the developing world. Proceedings of the National Academy of Sciences of the United States of America. 108: 7081-5. PMID 21482756 DOI: 10.1073/Pnas.1102149108 |
0.49 |
|
| 2011 |
Chao DL, Matrajt L, Basta NE, Sugimoto JD, Dean B, Bagwell DA, Oiulfstad B, Halloran ME, Longini IM. Planning for the control of pandemic influenza A (H1N1) in Los Angeles County and the United States. American Journal of Epidemiology. 173: 1121-30. PMID 21427173 DOI: 10.1093/Aje/Kwq497 |
0.414 |
|
| 2011 |
Sugimoto JD, Borse NN, Ta ML, Stockman LJ, Fischer GE, Yang Y, Halloran ME, Longini IM, Duchin JS. The effect of age on transmission of 2009 pandemic influenza A (H1N1) in a camp and associated households. Epidemiology (Cambridge, Mass.). 22: 180-7. PMID 21233714 DOI: 10.1097/Ede.0B013E3182060Ca5 |
0.402 |
|
| 2010 |
Yang Y, Halloran ME, Daniels MJ, Longini IM, Burke DS, Cummings DA. Modeling Competing Infectious Pathogens from a Bayesian Perspective: Application to Influenza Studies with Incomplete Laboratory Results. Journal of the American Statistical Association. 105: 1310-1322. PMID 21472041 DOI: 10.1198/Jasa.2010.Ap09581 |
0.436 |
|
| 2010 |
Matrajt L, Longini IM. Optimizing vaccine allocation at different points in time during an epidemic Plos One. 5. PMID 21085686 DOI: 10.1371/Journal.Pone.0013767 |
0.487 |
|
| 2010 |
Chao DL, Halloran ME, Longini IM. School opening dates predict pandemic influenza A(H1N1) outbreaks in the United States. The Journal of Infectious Diseases. 202: 877-80. PMID 20704486 DOI: 10.1086/655810 |
0.343 |
|
| 2010 |
Alsallaq RA, Schiffer JT, Longini IM, Wald A, Corey L, Abu-Raddad LJ. Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2. Sexually Transmitted Diseases. 37: 290-7. PMID 20351622 DOI: 10.1097/Olq.0B013E3181D3D023 |
0.507 |
|
| 2010 |
Chao DL, Halloran ME, Obenchain VJ, Longini IM. FluTE, a publicly available stochastic influenza epidemic simulation model. Plos Computational Biology. 6: e1000656. PMID 20126529 DOI: 10.1371/Journal.Pcbi.1000656 |
0.425 |
|
| 2010 |
Handel A, Longini IM, Antia R. Towards a quantitative understanding of the within-host dynamics of influenza A infections. Journal of the Royal Society, Interface / the Royal Society. 7: 35-47. PMID 19474085 DOI: 10.1098/Rsif.2009.0067 |
0.374 |
|
| 2009 |
Handel A, Longini IM, Antia R. Intervention strategies for an influenza pandemic taking into account secondary bacterial infections. Epidemics. 1: 185-95. PMID 20161493 DOI: 10.1016/J.Epidem.2009.09.001 |
0.431 |
|
| 2009 |
Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E, Longini IM. The transmissibility and control of pandemic influenza A (H1N1) virus. Science (New York, N.Y.). 326: 729-33. PMID 19745114 DOI: 10.1126/Science.1177373 |
0.498 |
|
| 2009 |
Basta NE, Chao DL, Halloran ME, Matrajt L, Longini IM. Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. American Journal of Epidemiology. 170: 679-86. PMID 19679750 DOI: 10.1093/Aje/Kwp237 |
0.501 |
|
| 2009 |
Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM, Dye C, Halloran ME. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proceedings of the National Academy of Sciences of the United States of America. 106: 13980-5. PMID 19666590 DOI: 10.1073/Pnas.0901720106 |
0.428 |
|
| 2009 |
Yang Y, Halloran ME, Longini IM. A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infections. Biostatistics (Oxford, England). 10: 390-403. PMID 19202152 DOI: 10.1093/Biostatistics/Kxn045 |
0.411 |
|
| 2009 |
Handel A, Longini IM, Antia R. Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details. Journal of Theoretical Biology. 256: 117-25. PMID 18952105 DOI: 10.1016/J.Jtbi.2008.09.021 |
0.315 |
|
| 2009 |
Sander B, Nizam A, Garrison LP, Postma MJ, Halloran ME, Longini IM. Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 12: 226-33. PMID 18671770 DOI: 10.1111/J.1524-4733.2008.00437.X |
0.353 |
|
| 2009 |
Cowling BJ, Ng S, Longini IM. A/H1N1 flu pandemic: Antiviral drugs: Distinguish treatment from prophylaxis Bmj (Online). 339: 589. DOI: 10.1136/Bmj.B3620 |
0.358 |
|
| 2008 |
Yang Y, Gilbert P, Longini IM, Halloran ME. A Bayesian Framework for Estimating Vaccine Efficacy per Infectious Contact. The Annals of Applied Statistics. 2: 1409-1431. PMID 19169384 DOI: 10.1214/08-Aoas193 |
0.512 |
|
| 2008 |
Basta NE, Halloran ME, Matrajt L, Longini IM. Estimating influenza vaccine efficacy from challenge and community-based study data. American Journal of Epidemiology. 168: 1343-52. PMID 18974084 DOI: 10.1093/Aje/Kwn259 |
0.512 |
|
| 2008 |
Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM, Self SG, Corey L. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. Plos One. 3: e2230. PMID 18493617 DOI: 10.1371/Journal.Pone.0002230 |
0.324 |
|
| 2008 |
Halloran ME, Ferguson NM, Eubank S, Longini IM, Cummings DA, Lewis B, Xu S, Fraser C, Vullikanti A, Germann TC, Wagener D, Beckman R, Kadau K, Barrett C, Macken CA, et al. Modeling targeted layered containment of an influenza pandemic in the United States. Proceedings of the National Academy of Sciences of the United States of America. 105: 4639-44. PMID 18332436 DOI: 10.1073/Pnas.0706849105 |
0.412 |
|
| 2007 |
Yang Y, Longini IM, Halloran ME. A Resampling-Based Test to Detect Person-To-Person Transmission of Infectious Disease. The Annals of Applied Statistics. 1: 211-228. PMID 19436773 DOI: 10.1214/07-Aoas105 |
0.313 |
|
| 2007 |
Yang Y, Longini IM, Halloran ME. A Data-Augmentation Method for Infectious Disease Incidence Data from Close Contact Groups. Computational Statistics & Data Analysis. 51: 6582-6595. PMID 18704156 DOI: 10.1016/J.Csda.2007.03.007 |
0.366 |
|
| 2007 |
Yang Y, Halloran ME, Sugimoto JD, Longini IM. Detecting human-to-human transmission of avian influenza A (H5N1). Emerging Infectious Diseases. 13: 1348-53. PMID 18252106 DOI: 10.3201/Eid1309.07-0111 |
0.346 |
|
| 2007 |
Handel A, Longini IM, Antia R. Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread. Plos Computational Biology. 3: e240. PMID 18069885 DOI: 10.1371/Journal.Pcbi.0030240 |
0.352 |
|
| 2007 |
Longini IM, Nizam A, Ali M, Yunus M, Shenvi N, Clemens JD. Controlling endemic cholera with oral vaccines. Plos Medicine. 4: e336. PMID 18044983 DOI: 10.1371/Journal.Pmed.0040336 |
0.475 |
|
| 2007 |
Abu-Raddad LJ, Boily MC, Self S, Longini IM. Analytic insights into the population level impact of imperfect prophylactic HIV vaccines. Journal of Acquired Immune Deficiency Syndromes (1999). 45: 454-67. PMID 17554215 DOI: 10.1097/Qai.0B013E3180959A94 |
0.479 |
|
| 2007 |
Halloran ME, Piedra PA, Longini IM, Gaglani MJ, Schmotzer B, Fewlass C, Herschler GB, Glezen WP. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. Vaccine. 25: 4038-45. PMID 17395338 DOI: 10.1016/J.Vaccine.2007.02.060 |
0.49 |
|
| 2007 |
Handel A, Longini IM, Antia R. What is the best control strategy for multiple infectious disease outbreaks? Proceedings. Biological Sciences / the Royal Society. 274: 833-7. PMID 17251095 DOI: 10.1098/Rspb.2006.0015 |
0.355 |
|
| 2007 |
Halloran ME, Hayden FG, Yang Y, Longini IM, Monto AS. Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. American Journal of Epidemiology. 165: 212-21. PMID 17088311 DOI: 10.1093/Aje/Kwj362 |
0.37 |
|
| 2007 |
Longini IM, Halloran ME, Nizam A, Yang Y, Xu S, Burke DS, Cummings DA, Epstein JM. Containing a large bioterrorist smallpox attack: a computer simulation approach. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. 11: 98-108. PMID 16899385 DOI: 10.1016/J.Ijid.2006.03.002 |
0.488 |
|
| 2006 |
Yang Y, Longini IM, Halloran ME. Design and Evaluation of Prophylactic Interventions Using Infectious Disease Incidence Data from Close Contact Groups. Journal of the Royal Statistical Society. Series C, Applied Statistics. 55: 317-330. PMID 22457545 DOI: 10.1111/J.1467-9876.2006.00539.X |
0.365 |
|
| 2006 |
Germann TC, Kadau K, Longini IM, Macken CA. Mitigation strategies for pandemic influenza in the United States Proceedings of the National Academy of Sciences of the United States of America. 103: 5935-5940. PMID 16585506 DOI: 10.1073/Pnas.0601266103 |
0.487 |
|
| 2006 |
Halloran ME, Longini IM. Public health. Community studies for vaccinating schoolchildren against influenza. Science (New York, N.Y.). 311: 615-6. PMID 16456066 DOI: 10.1126/Science.1122143 |
0.47 |
|
| 2005 |
Huq A, Sack RB, Nizam A, Longini IM, Nair GB, Ali A, Morris JG, Khan MN, Siddique AK, Yunus M, Albert MJ, Sack DA, Colwell RR. Critical factors influencing the occurrence of Vibrio cholerae in the environment of Bangladesh. Applied and Environmental Microbiology. 71: 4645-54. PMID 16085859 DOI: 10.1128/Aem.71.8.4645-4654.2005 |
0.325 |
|
| 2005 |
Longini IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DA, Halloran ME. Containing pandemic influenza at the source. Science (New York, N.Y.). 309: 1083-7. PMID 16079251 DOI: 10.1126/Science.1115717 |
0.461 |
|
| 2005 |
Regoes RR, Longini IM, Feinberg MB, Staprans SI. Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges. Plos Medicine. 2: e249. PMID 16018721 DOI: 10.1371/Journal.Pmed.0020249 |
0.397 |
|
| 2005 |
Patel R, Longini IM, Halloran ME. Finding optimal vaccination strategies for pandemic influenza using genetic algorithms. Journal of Theoretical Biology. 234: 201-12. PMID 15757679 DOI: 10.1016/J.Jtbi.2004.11.032 |
0.473 |
|
| 2005 |
Longini IM, Halloran ME. Strategy for distribution of influenza vaccine to high-risk groups and children. American Journal of Epidemiology. 161: 303-6. PMID 15692073 DOI: 10.1093/Aje/Kwi053 |
0.511 |
|
| 2005 |
Weycker D, Edelsberg J, Halloran ME, Longini IM, Nizam A, Ciuryla V, Oster G. Population-wide benefits of routine vaccination of children against influenza. Vaccine. 23: 1284-93. PMID 15652671 DOI: 10.1016/J.Vaccine.2004.08.044 |
0.502 |
|
| 2004 |
Glezen WP, Piedra PA, Longini IM, Halloran ME. Safety of cold-adapted live influenza vaccine. The Pediatric Infectious Disease Journal. 23: 593-4; author reply . PMID 15194854 DOI: 10.1097/00006454-200406000-00030 |
0.371 |
|
| 2004 |
Longini IM, Halloran ME, Nizam A, Yang Y. Containing Pandemic Influenza with Antiviral Agents American Journal of Epidemiology. 159: 623-633. PMID 15033640 DOI: 10.1093/Aje/Kwh092 |
0.497 |
|
| 2004 |
Gaglani MJ, Piedra PA, Herschler GB, Griffith ME, Kozinetz CA, Riggs MW, Fewlass C, Halloran ME, Longini IM, Glezen WP. Direct and Total Effectiveness of the Intranasal, Live-Attenuated, Trivalent Cold-Adapted Influenza Virus Vaccine Against the 2000-2001 Influenza A(H1N1) and B Epidemic in Healthy Children Archives of Pediatrics and Adolescent Medicine. 158: 65-73. PMID 14706961 DOI: 10.1001/Archpedi.158.1.65 |
0.422 |
|
| 2003 |
Halloran ME, Longini IM, Gaglani MJ, Piedra PA, Chu H, Herschler GB, Glezen WP. Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures American Journal of Epidemiology. 158: 305-311. PMID 12915495 DOI: 10.1093/Aje/Kwg163 |
0.471 |
|
| 2003 |
Hill AN, Longini IM. The critical vaccination fraction for heterogeneous epidemic models Mathematical Biosciences. 181: 85-106. PMID 12421553 DOI: 10.1016/S0025-5564(02)00129-3 |
0.456 |
|
| 2003 |
Weycker D, Edelsberg J, Halloran M, Longini I, Nizam A, Ciuryla V, Oster G. Pin19: Routine Childhood Vaccination Against Influenza:An Analysis Of Clinical And Economic Benefits Value in Health. 6: 257-258. DOI: 10.1016/S1098-3015(10)63996-4 |
0.466 |
|
| 2002 |
Halloran ME, Longini IM, Nizam A, Yang Y. Containing bioterrorist smallpox Science. 298: 1428-1432. PMID 12434061 DOI: 10.1126/Science.1074674 |
0.468 |
|
| 2002 |
Halloran ME, Longini IM, Cowart DM, Nizam A. Community interventions and the epidemic prevention potential. Vaccine. 20: 3254-62. PMID 12213394 DOI: 10.1016/S0264-410X(02)00316-X |
0.408 |
|
| 2002 |
Longini IM, Yunus M, Zaman K, Siddique AK, Sack RB, Nizam A. Epidemic and endemic cholera trends over a 33-year period in Bangladesh Journal of Infectious Diseases. 186: 246-251. PMID 12134262 DOI: 10.1086/341206 |
0.392 |
|
| 2002 |
Longini IM, Halloran ME, Nizam A. Model-based estimation of vaccine effects from community vaccine trials Statistics in Medicine. 21: 481-495. PMID 11836731 DOI: 10.1002/Sim.994 |
0.484 |
|
| 2002 |
Hudgens MG, Longini IM, Vanichseni S, Hu DJ, Kitayaporn D, Mock PA, Halloran ME, Satten GA, Choopanya K, Mastro TD. Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. American Journal of Epidemiology. 155: 159-68. PMID 11790680 DOI: 10.1093/Aje/155.2.159 |
0.31 |
|
| 2001 |
Halloran ME, Longini IM. Using Validation Sets for Outcomes and Exposure to Infection in Vaccine Field Studies American Journal of Epidemiology. 154: 391-398. PMID 11532779 DOI: 10.1093/Aje/154.5.391 |
0.505 |
|
| 2001 |
Hudgens MG, Longini IM, Halloran ME, Choopanya K, Vanichseni S, Kitayaporn D, Mastro TD, Mock PA. Estimating the transmission probability of human immunodeficiency virus in injecting drug users in Thailand Journal of the Royal Statistical Society. Series C: Applied Statistics. 50: 1-14. DOI: 10.1111/1467-9876.00216 |
0.339 |
|
| 2000 |
Guihenneuc-Jouyaux C, Richardson S, Longini IM. Modeling markers of disease progression by a hidden Markov process: Application to characterizing CD4 cell decline Biometrics. 56: 733-741. PMID 10985209 DOI: 10.1111/J.0006-341X.2000.00733.X |
0.306 |
|
| 2000 |
Longini IM, Halloran ME, Nizam A, Wolff M, Mendelman PM, Fast PE, Belshe RB. Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: Implications for influenza epidemic control Vaccine. 18: 1902-1909. PMID 10699339 DOI: 10.1016/S0264-410X(99)00419-3 |
0.526 |
|
| 1999 |
Golm GT, Halloran ME, Longini IM. Semiparametric methods for multiple exposure mismeasurement and a bivariate outcome in HIV vaccine trials Biometrics. 55: 94-101. PMID 11318183 DOI: 10.1111/J.0006-341X.1999.00094.X |
0.454 |
|
| 1999 |
Datta S, Halloran ME, Longini IM. Efficiency of estimating vaccine efficacy for susceptibility and infectiousness: Randomization by individual versus household Biometrics. 55: 792-798. PMID 11315008 DOI: 10.1111/J.0006-341X.1999.00792.X |
0.491 |
|
| 1999 |
Halloran ME, Longini IM, Struchiner CJ. Design and interpretation of vaccine field studies Epidemiologic Reviews. 21: 73-88. PMID 10520474 DOI: 10.1093/Oxfordjournals.Epirev.A017990 |
0.428 |
|
| 1999 |
Longini IM, Hudgens MG, Halloran ME, Sagatelian K. A Markov model for measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV vaccines Statistics in Medicine. 18: 53-68. PMID 9990692 DOI: 10.1002/(Sici)1097-0258(19990115)18:1<53::Aid-Sim996>3.0.Co;2-0 |
0.475 |
|
| 1999 |
Durham LK, Halloran ME, Longini IM, Manatunga AK. Comparison of two smoothing methods for exploring waning vaccine effects Journal of the Royal Statistical Society. Series C: Applied Statistics. 48: 395-407. DOI: 10.1111/1467-9876.00160 |
0.481 |
|
| 1998 |
Golm GT, Halloran ME, Longini IM. Semi-parametric models for mismeasured exposure information in vaccine trials Statistics in Medicine. 17: 2335-2352. PMID 9819831 DOI: 10.1002/(Sici)1097-0258(19981030)17:20<2335::Aid-Sim929>3.0.Co;2-C |
0.457 |
|
| 1998 |
Longini IM, Sagatelian K, Rida WN, Halloran ME. Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations Statistics in Medicine. 17: 1121-1136. PMID 9618773 DOI: 10.1002/(Sici)1097-0258(19980530)17:10<1121::Aid-Sim824>3.0.Co;2-E |
0.511 |
|
| 1998 |
Kathryn Durham L, Longini IM, Elizabeth Halloran M, Clemens JD, Nizam A, Rao M. Estimation of vaccine efficacy in the presence of waning: Application to cholera vaccines American Journal of Epidemiology. 147: 948-959. PMID 9596473 DOI: 10.1093/Oxfordjournals.Aje.A009385 |
0.483 |
|
| 1998 |
Datta S, Halloran ME, Longini IM. Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacy Statistics in Medicine. 17: 185-200. PMID 9483728 DOI: 10.1002/(Sici)1097-0258(19980130)17:2<185::Aid-Sim732>3.0.Co;2-4 |
0.471 |
|
| 1997 |
Elizabeth Halloran M, Struchiner CJ, Longini IM. Study designs for evaluating different efficacy and effectiveness aspects of vaccines American Journal of Epidemiology. 146: 789-803. PMID 9384199 DOI: 10.1093/Oxfordjournals.Aje.A009196 |
0.485 |
|
| 1996 |
Longini IM, Datta S, Halloran ME. Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 13: 440-447. PMID 8970471 DOI: 10.1097/00042560-199612150-00007 |
0.411 |
|
| 1996 |
Halloran ME, Longini IM, Struchiner CJ. Estimability and interpretation of vaccine efficacy using frailty mixing models American Journal of Epidemiology. 144: 83-97. PMID 8659489 DOI: 10.1093/Oxfordjournals.Aje.A008858 |
0.515 |
|
| 1996 |
Longini IM, Halloran ME. A frailty mixture model for estimating vaccine efficacy Journal of the Royal Statistical Society. Series C: Applied Statistics. 45: 165-173. DOI: 10.2307/2986152 |
0.498 |
|
| 1996 |
Rhodes PH, Halloran ME, Longini IM. Counting Process Models for Infectious Disease Data: Distinguishing Exposure to Infection from Susceptibility Journal of the Royal Statistical Society Series B-Methodological. 58: 751-762. DOI: 10.1111/J.2517-6161.1996.Tb02113.X |
0.366 |
|
| 1995 |
Haber M, Orenstein WA, Halloran ME, Longini IM. The effect of disease prior to an outbreak on estimates of vaccine efficacy following the outbreak American Journal of Epidemiology. 141: 980-990. PMID 7741128 DOI: 10.1093/Oxfordjournals.Aje.A117365 |
0.519 |
|
| 1995 |
Haber M, Halloran ME, Longini IM, Watelet L. Estimation of Vaccine Efficacy in Non‐Randomly Mixing Populations Biometrical Journal. 37: 25-38. DOI: 10.1002/Bimj.4710370103 |
0.498 |
|
| 1994 |
Halloran ME, Longini IM, Haber MJ, Struchiner CJ, Brunet RC. Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field Statistics in Medicine. 13: 357-377. PMID 8177986 |
0.392 |
|
| 1994 |
Jacquez JA, Koopman JS, Simon CP, Longini IM. Role of the primary infection in epidemics of HIV infection in gay cohorts. Journal of Acquired Immune Deficiency Syndromes. 7: 1169-84. PMID 7932084 DOI: 10.1097/00042560-199505010-00020 |
0.348 |
|
| 1994 |
Satten GA, Mastro TD, Longini IM. Modelling the female-to-male per-act HIV transmission probability in an emerging epidemic in Asia Statistics in Medicine. 13: 2097-2106. PMID 7846413 DOI: 10.1002/Sim.4780131918 |
0.355 |
|
| 1993 |
Longini IM, Halloran ME, Haber M, Chen RT. Measuring vaccine efficacy from epidemics of acute infectious agents Statistics in Medicine. 12: 249-263. PMID 8456210 |
0.33 |
|
| 1993 |
Longini IM, Halloran ME, Haber M. Estimation of vaccine efficacy from epidemics of acute infectious agents under vaccine-related heterogeneity Mathematical Biosciences. 117: 271-281. PMID 8400580 DOI: 10.1016/0025-5564(93)90028-9 |
0.497 |
|
| 1993 |
Longini IM, Clark WS, Karon JM. Effect of routine use of therapy in slow ing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort American Journal of Epidemiology. 137: 1229-1240. PMID 8100682 DOI: 10.1093/Oxfordjournals.Aje.A116625 |
0.316 |
|
| 1992 |
Longini IM, Byers RH, Hessol NA, Tan WY. Estimating the stage‐specific numbers of HIV infection using a markov model and back‐calculation Statistics in Medicine. 11: 831-843. PMID 1594820 DOI: 10.1002/Sim.4780110612 |
0.32 |
|
| 1992 |
Halloran ME, Haber M, Longini IM. Interpretation and estimation of vaccine efficacy under heterogeneity American Journal of Epidemiology. 136: 328-343. PMID 1415152 DOI: 10.1093/Oxfordjournals.Aje.A116498 |
0.492 |
|
| 1992 |
Rampey AH, Longini IM, Haber M, Monto AS. A discrete-time model for the statistical analysis of infectious disease incidence data. Biometrics. 48: 117-128. DOI: 10.2307/2532743 |
0.367 |
|
| 1991 |
Haber M, Longini IM, Halloran ME. Measures of the effects of vaccination in a randomly mixing population International Journal of Epidemiology. 20: 300-310. PMID 2066239 DOI: 10.1093/Ije/20.1.300 |
0.511 |
|
| 1991 |
Koopman JS, Longini IM, Jacquez JA, Simon CP, Ostrow DG, Martin WR, Woodcock DM. Assessing risk factors for transmission of infection. American Journal of Epidemiology. 133: 1199-209. PMID 2063828 DOI: 10.1093/Oxfordjournals.Aje.A115832 |
0.309 |
|
| 1991 |
Koopman JS, Prevots DR, Mann MAV, Dantes HG, Aquino MLZ, Longini IM, Amor JS. Determinants and predictors of dengue infection in Mexico American Journal of Epidemiology. 133: 1168-1178. PMID 2035520 DOI: 10.1093/Oxfordjournals.Aje.A115829 |
0.319 |
|
| 1991 |
Haber M, Longini IM, Halloran ME. Estimation of vaccine efficacy in outbreaks of acute infectious diseases. Statistics in Medicine. 10: 1573-1584. PMID 1947513 DOI: 10.1002/Sim.4780101009 |
0.488 |
|
| 1991 |
Halloran ME, Haber M, Longini IM, Struchiner CJ. Direct and indirect effects in vaccine efficacy and effectiveness American Journal of Epidemiology. 133: 323-331. PMID 1899778 |
0.347 |
|
| 1991 |
Hethcote HW, Van Ark JW, Longini IM. A simulation model of AIDS in San Francisco: I. model formulation and parameter estimation Mathematical Biosciences. 106: 203-222. PMID 1806102 DOI: 10.1016/0025-5564(91)90077-V |
0.322 |
|
| 1991 |
Addy CL, Longini IM, Haber M. A generalized stochastic model for the analysis of infectious disease final size data Biometrics. 47: 961-974. PMID 1742449 DOI: 10.2307/2532652 |
0.376 |
|
| 1990 |
Ackerman E, Longini IM, Seaholm SK, Hedin AS. Simulation of mechanisms of viral interference in influenza. International Journal of Epidemiology. 19: 444-54. PMID 2376460 DOI: 10.1093/Ije/19.2.444 |
0.386 |
|
| 1990 |
Longini IM, Haber MJ, Halloran ME. Direct and indirect effects of vaccines: an annotation on the estimation of the vaccine efficacy from outbreaks caused by acute infection agents such as measles Boletin Medico Del Hospital Infantil De Mexico. 47: 516-519. PMID 2206419 |
0.393 |
|
| 1989 |
Longini IM, Haber M, Koopman JS. Re: "use of modeling in infectious disease epidemiology" American Journal of Epidemiology. 130: 619-620. PMID 2764009 DOI: 10.1093/Oxfordjournals.Aje.A115382 |
0.305 |
|
| 1989 |
Longini IM. A mathematical model for predicting the geographic spread of new infectious agents Mathematical and Computer Modelling. 12: 1179-1180. DOI: 10.1016/0025-5564(88)90075-2 |
0.406 |
|
| 1988 |
Longini IM, Koopman JS, Haber M, Cotsonis GA. Statistical inference for infectious diseases: Risk-specific household and community transmission parameters American Journal of Epidemiology. 128: 845-859. PMID 3421247 DOI: 10.1093/Oxfordjournals.Aje.A115038 |
0.394 |
|
| 1988 |
Dantes HG, Koopman JS, Addy CL, Zarate ML, Marin MAV, Longini IM, Guttierez ES, Rodriguez VA, Garcia LG, Mirelles ER. Dengue epidemics on the pacific coast of Mexico International Journal of Epidemiology. 17: 178-186. PMID 3384535 DOI: 10.1093/Ije/17.1.178 |
0.367 |
|
| 1988 |
Longini IM, Monto AS. Efficacy of virucidal nasal tissues in interrupting familial transmission of respiratory agents: A field trial in tecumseh, Michigan American Journal of Epidemiology. 128: 639-644. PMID 2843040 DOI: 10.1093/Oxfordjournals.Aje.A115011 |
0.357 |
|
| 1988 |
Haber M, Longini IM, Cotsonis GA. Models for the statistical analysis of infectious disease data. Biometrics. 44: 163. DOI: 10.2307/2531904 |
0.348 |
|
| 1988 |
Longini IM. Spatial aspects of influenza epidemics: Andrew D. Cliff, Peter Haggett, and J. Keith Ord, Pion Limited, London, 1986, 280 pp., $52.50 (hardback). Bellman Prize in Mathematical Biosciences. 89: 237-239. DOI: 10.1016/0025-5564(88)90104-6 |
0.317 |
|
| 1986 |
Longini IM. The generalized discrete-time epidemic model with immunity: a synthesis Mathematical Biosciences. 82: 19-41. DOI: 10.1016/0025-5564(86)90003-9 |
0.345 |
|
| 1985 |
Monto AS, Koopman JS, Longini IM. Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981 American Journal of Epidemiology. 121: 811-822. PMID 4014174 DOI: 10.1093/Oxfordjournals.Aje.A114052 |
0.36 |
|
| 1985 |
A. Rvachev L, Longini IM. A mathematical model for the global spread of influenza Mathematical Biosciences. 75: 3-22. DOI: 10.1016/0025-5564(85)90064-1 |
0.401 |
|
| 1984 |
Longini IM, Seaholm SK, Ackerman E, Koopman JS, Monto AS. Simulation studies of influenza epidemics: assessment of parameter estimation and sensitivity. International Journal of Epidemiology. 13: 496-501. PMID 6519891 DOI: 10.1093/Ije/13.4.496 |
0.376 |
|
| 1984 |
Longini IM, Monto AS, Koopman JS. Statistical procedures for estimating the community probability of illness in family studies: Rhinovirus and influenza International Journal of Epidemiology. 13: 99-106. PMID 6321368 DOI: 10.1093/Ije/13.1.99 |
0.366 |
|
| 1982 |
Longini IM, Koopman JS, Monto AS, Fox JP. Estimating household and community transmission parameters for influenza American Journal of Epidemiology. 115: 736-751. PMID 7081204 DOI: 10.1093/Oxfordjournals.Aje.A113356 |
0.436 |
|
| 1982 |
Longini IM, Koopman JS. Household and Community Transmission Parameters from Final Distributions of Infections in Households Biometrics. 38: 115. DOI: 10.2307/2530294 |
0.374 |
|
| 1980 |
Longini IM. A chain binomial model of endemicity Mathematical Biosciences. 50: 85-93. DOI: 10.1016/0025-5564(80)90123-6 |
0.324 |
|
| 1978 |
Longini IM, Ackerman E, Elveback LR. An optimization model for influenza A epidemics Mathematical Biosciences. 38: 141-157. DOI: 10.1016/0025-5564(78)90023-8 |
0.465 |
|
| Show low-probability matches. |